Literature DB >> 15847723

Human Metapneumovirus: An Important Cause of Respiratory Disease in Children and Adults.

John V Williams1.   

Abstract

Human metapneumovirus is a paramyxovirus that was discovered in 2001 in the Netherlands. Epidemiologic studies have shown it to be a major cause of acute respiratory tract disease in normal infants and children worldwide, with a seasonal occurrence and spectrum of clinical illness most similar to the closely related respiratory syncytial virus. The greatest prevalence of severe disease requiring hospitalization in otherwise healthy children appears to be in those aged between 6 and 12 months, older than the peak age of hospitalizations for respiratory syncytial virus. Human metapneumovirus is also a significant cause of acute respiratory disease in adults, particularly the elderly and those with comorbid conditions such as chronic obstructive pulmonary disease, asthma, and cancer. Because there is no rapid diagnostic assay, reverse transcriptase polymerase chain reaction is most widely used. Animal models have been developed, and candidate live-attenuated vaccines are in preclinical trials, offering the potential for future interventions in high-risk groups.

Entities:  

Year:  2005        PMID: 15847723      PMCID: PMC3347970          DOI: 10.1007/s11908-005-0036-7

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  48 in total

1.  Human metapneumovirus in a haematopoietic stem cell transplant recipient with fatal lower respiratory tract disease.

Authors:  P A Cane; B G van den Hoogen; S Chakrabarti; C D Fegan; A D M E Osterhaus
Journal:  Bone Marrow Transplant       Date:  2003-02       Impact factor: 5.483

2.  Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - a compassionate use experience.

Authors:  J P DeVincenzo; R L Hirsch; R J Fuentes; F H Top
Journal:  Bone Marrow Transplant       Date:  2000-01       Impact factor: 5.483

3.  Human metapneumovirus infections in young and elderly adults.

Authors:  Ann R Falsey; Dean Erdman; Larry J Anderson; Edward E Walsh
Journal:  J Infect Dis       Date:  2003-02-24       Impact factor: 5.226

4.  The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice.

Authors:  F W Henderson; W A Clyde; A M Collier; F W Denny; R J Senior; C I Sheaffer; W G Conley; R M Christian
Journal:  J Pediatr       Date:  1979-08       Impact factor: 4.406

5.  Molecular assays for detection of human metapneumovirus.

Authors:  Ian M Mackay; Kevin C Jacob; Daniel Woolhouse; Katharine Waller; Melanie W Syrmis; David M Whiley; David J Siebert; Michael Nissen; Theo P Sloots
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

6.  Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients.

Authors:  Bernadette G van den Hoogen; Gerard J J van Doornum; John C Fockens; Jan J Cornelissen; Walter E P Beyer; Ronald de Groot; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  J Infect Dis       Date:  2003-10-27       Impact factor: 5.226

7.  Impact of human metapneumovirus in childhood: comparison with respiratory syncytial virus and influenza viruses.

Authors:  Samantha Bosis; Susanna Esposito; Hubert G M Niesters; Piero Crovari; Albert D M E Osterhaus; Nicola Principi
Journal:  J Med Virol       Date:  2005-01       Impact factor: 2.327

8.  A newly discovered human pneumovirus isolated from young children with respiratory tract disease.

Authors:  B G van den Hoogen; J C de Jong; J Groen; T Kuiken; R de Groot; R A Fouchier; A D Osterhaus
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

9.  Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child.

Authors:  Gilles Pelletier; Pierre Déry; Yacine Abed; Guy Boivin
Journal:  Emerg Infect Dis       Date:  2002-09       Impact factor: 6.883

10.  Human metapneumovirus in severe respiratory syncytial virus bronchiolitis.

Authors:  Julie Greensill; Paul S McNamara; Winifred Dove; Brian Flanagan; Rosalind L Smyth; C Anthony Hart
Journal:  Emerg Infect Dis       Date:  2003-03       Impact factor: 6.883

View more
  19 in total

1.  A duplex recombinant viral nucleoprotein microbead immunoassay for simultaneous detection of seroresponses to human respiratory syncytial virus and metapneumovirus infections.

Authors:  Yange Zhang; W Abdullah Brooks; Doli Goswami; Mustafizur Rahman; Stephen P Luby; Dean D Erdman
Journal:  J Virol Methods       Date:  2014-05-23       Impact factor: 2.014

2.  Role of metapneumovirus in viral respiratory infections in young children.

Authors:  José Ordás; José Antonio Boga; Marta Alvarez-Argüelles; Laura Villa; Cristina Rodríguez-Dehli; María de Oña; Julián Rodríguez; Santiago Melón
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

3.  Lung CD8+ T Cell Impairment Occurs during Human Metapneumovirus Infection despite Virus-Like Particle Induction of Functional CD8+ T Cells.

Authors:  Sherry C Wen; Jennifer E Schuster; Pavlo Gilchuk; Kelli L Boyd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

4.  A Sendai virus recombinant vaccine expressing a gene for truncated human metapneumovirus (hMPV) fusion protein protects cotton rats from hMPV challenge.

Authors:  Charles J Russell; Bart G Jones; Robert E Sealy; Sherri L Surman; John N Mason; Randall T Hayden; Ralph A Tripp; Toru Takimoto; Julia L Hurwitz
Journal:  Virology       Date:  2017-06-09       Impact factor: 3.616

5.  Acute clearance of human metapneumovirus occurs independently of natural killer cells.

Authors:  Sherry C Wen; Sharon J Tollefson; Monika Johnson; Pavlo Gilchuk; Kelli L Boyd; Bryan Shepherd; Sebastian Joyce; John V Williams
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

6.  Human metapneumovirus induces more severe disease and stronger innate immune response in BALB/c mice as compared with respiratory syncytial virus.

Authors:  Barbara Huck; Dieter Neumann-Haefelin; Annette Schmitt-Graeff; Markus Weckmann; Jörg Mattes; Stephan Ehl; Valeria Falcone
Journal:  Respir Res       Date:  2007-01-29

7.  Human metapneumovirus infection among children, Bangladesh.

Authors:  W Abdullah Brooks; Dean Erdman; Pauline Terebuh; Alexander Klimov; Doli Goswami; Amina Tahia Sharmeen; Tasnim Azim; Stephen Luby; Carolyn Bridges; Robert Breiman
Journal:  Emerg Infect Dis       Date:  2007-10       Impact factor: 6.883

Review 8.  Emerging Advances of Nanotechnology in Drug and Vaccine Delivery against Viral Associated Respiratory Infectious Diseases (VARID).

Authors:  Amir Seyfoori; Mahdieh Shokrollahi Barough; Pooneh Mokarram; Mazaher Ahmadi; Parvaneh Mehrbod; Alireza Sheidary; Tayyebeh Madrakian; Mohammad Kiumarsi; Tavia Walsh; Kielan D McAlinden; Chandra C Ghosh; Pawan Sharma; Amir A Zeki; Saeid Ghavami; Mohsen Akbari
Journal:  Int J Mol Sci       Date:  2021-06-28       Impact factor: 5.923

9.  Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice.

Authors:  Jorge A Soto; Nicolás M S Gálvez; Gaspar A Pacheco; Gisela Canedo-Marroquín; Susan M Bueno; Alexis M Kalergis
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

Review 10.  Infections and their role in childhood asthma inception.

Authors:  Amy O Thomas; Robert F Lemanske; Daniel J Jackson
Journal:  Pediatr Allergy Immunol       Date:  2013-11-17       Impact factor: 6.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.